Registration of Amyotrophic Lateral Sclerosis: Validity in the Danish National Patient Registry

Abstract

Purpose

Health care databases are a valuable source for epidemiological research on amyotrophic lateral sclerosis (ALS) if diagnosis codes are valid. We evaluated the validity of the diagnostic codes for ALS in the Danish National Patient Registry (DNPR).

Patients and Methods

We obtained data from the DNPR for all adult (>17 years) patients registered with ALS in Denmark between 1987 and 2022 (median population of 4.2 million during the study period). We randomly selected adult patients living in the North Denmark Region and Central Denmark Region (median population 1.4 million), with a primary discharge diagnosis code of ALS, diagnosed at three departments of neurology. We retrieved and reviewed medical records and estimated the positive predictive value (PPV) of the ALS diagnosis.

Results

Over 36 years, we identified 5679 patients. From the validation cohort of 300 patients, we were able to retrieve 240 (80%) medical records, and 215 ALS diagnoses were confirmed. The overall positive predictive value was 89.6% (95% confidence interval (CI): 85.1–92.8). The highest PPV was achieved for diagnoses registered for patients aged ≥70 years (93.8; 95% CI: 86.2–97.3) compared to patients <60 years (83.4; 95% CI: 73.3–90.7).

Conclusion

We found a high PPV of primary diagnostic codes for ALS from Danish departments of neurology, demonstrating high validity. Thus, the DNPR is a well–suited data source for large-scale epidemiological research on ALS.

Keywords:

• registries
• positive predictive value
• international classification of disease codes
• epidemiology
• amyotrophic lateral sclerosis

Disclosure

The authors report no conflicts of interest in this work.

Additional information

Funding

This work received funding from the Health Research Foundation of the Central Denmark Region (A3520) and from the Department of Clinical Medicine Aarhus University & Aarhus University Hospital. We are grateful to both donors.